Press Releases
Page 2

Press Releases

March 8, 2024

NurExone establishing State-of-the-Art Research and Development Facility in Haifa, Israel

March 1, 2024

NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit

February 2, 2024

Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant

January 17, 2024

NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market

January 5, 2024

NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million

November 29, 2023

NurExone Biologic Extends Spinal Cord Injury Therapy Portfolio With New RNA Sequences Promoting Healing and Regeneration

November 24, 2023

NurExone Reports Third Quarter 2023 Financial Results and Provides Corporate Update

October 30, 2023

NurExone Biologic Receives FDA Orphan-Drug Designation, Accelerating Development of ExoPTEN therapy for Acute Spinal Cord Injury Treatment

October 19, 2023

Appointment of Professor Teo Forcht Dagi to Scientific Advisory Board and Advisory Committee

Set layout popup